InspireMD, Inc. (NSPR)
USD 2.53
(-5.87%)
USD 2.53
(-5.87%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 8.14 Million USD | 12.15% |
| 2022 | 7.26 Million USD | 17.48% |
| 2021 | 6.18 Million USD | 10.08% |
| 2020 | 5.61 Million USD | 24.84% |
| 2019 | 4.49 Million USD | 27.57% |
| 2018 | 3.52 Million USD | 4.29% |
| 2017 | 3.38 Million USD | -37.0% |
| 2016 | 5.36 Million USD | -38.5% |
| 2015 | 8.72 Million USD | -38.76% |
| 2014 | 14.24 Million USD | -7.05% |
| 2013 | 15.32 Million USD | 44.21% |
| 2012 | 10.62 Million USD | 186.39% |
| 2011 | 3.71 Million USD | 44909.1% |
| 2010 | 8245.00 USD | 153.69% |
| 2009 | 3250.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 8.89 Million USD | 28.17% |
| 2024 Q1 | 6.94 Million USD | -14.75% |
| 2023 Q3 | 6.76 Million USD | -0.91% |
| 2023 FY | 8.14 Million USD | 12.15% |
| 2023 Q1 | 6.49 Million USD | -10.54% |
| 2023 Q2 | 6.82 Million USD | 5.08% |
| 2023 Q4 | 8.14 Million USD | 20.39% |
| 2022 Q2 | 7.02 Million USD | 28.48% |
| 2022 Q3 | 6.19 Million USD | -11.86% |
| 2022 Q4 | 7.26 Million USD | 17.27% |
| 2022 Q1 | 5.46 Million USD | -11.54% |
| 2022 FY | 7.26 Million USD | 17.48% |
| 2021 Q4 | 6.18 Million USD | 11.49% |
| 2021 FY | 6.18 Million USD | 10.08% |
| 2021 Q3 | 5.54 Million USD | -0.04% |
| 2021 Q2 | 5.54 Million USD | 18.46% |
| 2021 Q1 | 4.68 Million USD | -16.62% |
| 2020 Q1 | 3.9 Million USD | -13.1% |
| 2020 Q2 | 4.52 Million USD | 15.81% |
| 2020 FY | 5.61 Million USD | 24.84% |
| 2020 Q3 | 4.32 Million USD | -4.35% |
| 2020 Q4 | 5.61 Million USD | 29.68% |
| 2019 Q3 | 3.72 Million USD | 0.43% |
| 2019 Q4 | 4.49 Million USD | 20.69% |
| 2019 FY | 4.49 Million USD | 27.57% |
| 2019 Q1 | 4.41 Million USD | 25.3% |
| 2019 Q2 | 3.71 Million USD | -16.01% |
| 2018 Q4 | 3.52 Million USD | 18.25% |
| 2018 Q3 | 2.98 Million USD | -44.52% |
| 2018 FY | 3.52 Million USD | 4.29% |
| 2018 Q1 | 6.24 Million USD | 84.64% |
| 2018 Q2 | 5.37 Million USD | -13.91% |
| 2017 Q2 | 3.16 Million USD | 13.12% |
| 2017 Q1 | 2.79 Million USD | -47.85% |
| 2017 Q3 | 3.33 Million USD | 5.31% |
| 2017 Q4 | 3.38 Million USD | 1.41% |
| 2017 FY | 3.38 Million USD | -37.0% |
| 2016 Q1 | 7.63 Million USD | -12.44% |
| 2016 FY | 5.36 Million USD | -38.5% |
| 2016 Q4 | 5.36 Million USD | -13.87% |
| 2016 Q2 | 8.11 Million USD | 6.21% |
| 2016 Q3 | 6.22 Million USD | -23.22% |
| 2015 Q1 | 12.33 Million USD | -13.39% |
| 2015 Q4 | 8.72 Million USD | -15.59% |
| 2015 Q3 | 10.33 Million USD | -7.61% |
| 2015 Q2 | 11.18 Million USD | -9.34% |
| 2015 FY | 8.72 Million USD | -38.76% |
| 2014 Q2 | 16.75 Million USD | 5.43% |
| 2014 FY | 14.24 Million USD | -7.05% |
| 2014 Q1 | 15.89 Million USD | 0.0% |
| 2014 Q4 | 14.24 Million USD | -12.45% |
| 2014 Q3 | 16.27 Million USD | -2.88% |
| 2013 FY | 15.32 Million USD | 44.21% |
| 2013 Q2 | 4.64 Million USD | -64.83% |
| 2013 Q3 | 4.67 Million USD | 0.78% |
| 2013 Q1 | 13.2 Million USD | 15.86% |
| 2012 Q4 | 11.39 Million USD | -20.72% |
| 2012 Q3 | 14.37 Million USD | 35.22% |
| 2012 FY | 10.62 Million USD | 186.39% |
| 2012 Q1 | 3.72 Million USD | 0.38% |
| 2012 Q2 | 10.62 Million USD | 185.32% |
| 2011 Q1 | 4.99 Million USD | 50339.17% |
| 2011 FY | 3.71 Million USD | 44909.1% |
| 2011 Q2 | 4.18 Million USD | -16.27% |
| 2011 Q3 | 3.85 Million USD | -7.84% |
| 2011 Q4 | 3.71 Million USD | -3.74% |
| 2010 Q1 | 8245.00 USD | 0.0% |
| 2010 Q2 | 8245.00 USD | 0.0% |
| 2010 Q3 | 8245.00 USD | 0.0% |
| 2010 FY | 8245.00 USD | 153.69% |
| 2010 Q4 | 9905.00 USD | 20.13% |
| 2009 Q2 | 3250.00 USD | 0.0% |
| 2009 FY | 3250.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 84.114% |
| BrainsWay Ltd. | 15.31 Million USD | 46.833% |
| Cerus Corporation | 144.3 Million USD | 94.358% |
| Envoy Medical, Inc. | 9.4 Million USD | 13.401% |
| electroCore, Inc. | 8.94 Million USD | 8.977% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -52.415% |
| IceCure Medical Ltd | 4.24 Million USD | -91.712% |
| Inogen, Inc. | 121.38 Million USD | 93.292% |
| OrthoPediatrics Corp. | 72.56 Million USD | 88.779% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 72.476% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -155.881% |
| MaxCyte, Inc. | 36.1 Million USD | 77.45% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -340.606% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1814.499% |
| Orthofix Medical Inc. | 326.58 Million USD | 97.507% |
| PAVmed Inc | 57.13 Million USD | 85.75% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 68.024% |
| RxSight, Inc. | 22.18 Million USD | 63.304% |
| Sight Sciences, Inc. | 46.43 Million USD | 82.466% |
| SI-BONE, Inc. | 61.05 Million USD | 86.663% |
| TELA Bio, Inc. | 59.16 Million USD | 86.239% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 92.856% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 21.097% |
| Acutus Medical, Inc. | 54.83 Million USD | 85.153% |
| Talis Biomedical Corporation | 29.22 Million USD | 72.139% |
| Spectral AI, Inc. | 12.4 Million USD | 34.344% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 64.805% |
| CVRx, Inc. | 39.28 Million USD | 79.273% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 31.912% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -235.158% |
| Bioventus Inc. | 589.79 Million USD | 98.62% |
| Venus Concept Inc. | 107.1 Million USD | 92.398% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 84.24% |
| LivaNova PLC | 1.15 Billion USD | 99.293% |
| 908 Devices Inc. | 37.49 Million USD | 78.282% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 98.843% |
| Nemaura Medical Inc. | 26.37 Million USD | 69.133% |
| NeuroPace, Inc. | 86.99 Million USD | 90.641% |
| LENSAR, Inc. | 22.4 Million USD | 63.666% |
| Apyx Medical Corporation | 52.31 Million USD | 84.437% |
| Cutera, Inc. | 518.12 Million USD | 98.429% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 72.238% |
| BioSig Technologies, Inc. | 4.68 Million USD | -73.789% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 86.05% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 62.109% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.629% |
| Axonics, Inc. | 82.35 Million USD | 90.114% |
| Outset Medical, Inc. | 190.91 Million USD | 95.735% |
| IRIDEX Corporation | 24.91 Million USD | 67.32% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 93.432% |
| IRadimed Corporation | 20.73 Million USD | 60.735% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -386.38% |
| INVO Bioscience, Inc. | 19.99 Million USD | 59.28% |
| Telesis Bio, Inc. | 40.87 Million USD | 80.08% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 80.039% |
| Varex Imaging Corporation | 668.6 Million USD | 98.782% |
| Quipt Home Medical Corp. | 136.29 Million USD | 94.026% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -127.94% |
| Pulmonx Corporation | 60.63 Million USD | 86.572% |
| Dynatronics Corporation | 11.78 Million USD | 30.884% |
| Modular Medical, Inc. | 2.27 Million USD | -258.363% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -100.344% |
| Semler Scientific, Inc. | 6.27 Million USD | -29.856% |
| InMode Ltd. | 75.91 Million USD | 89.275% |
| Bruker Corporation | 2.83 Billion USD | 99.713% |
| Cytosorbents Corporation | 29.98 Million USD | 72.847% |
| DexCom, Inc. | 4.19 Billion USD | 99.806% |
| Align Technology, Inc. | 2.45 Billion USD | 99.668% |
| Viveve Medical, Inc. | 10.84 Million USD | 24.938% |
| ZimVie Inc. | 795.85 Million USD | 98.977% |
| Movano Inc. | 5.97 Million USD | -36.336% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 92.216% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1814.499% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 31.912% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 98.726% |
| Profound Medical Corp. | 12.66 Million USD | 35.717% |
| Insulet Corporation | 1.85 Billion USD | 99.561% |
| enVVeno Medical Corporation | 2.43 Million USD | -234.374% |
| Surmodics, Inc. | 65.82 Million USD | 87.63% |
| iCAD, Inc. | 8 Million USD | -1.762% |
| Nuwellis, Inc. | 6.78 Million USD | -20.088% |
| Biotricity, Inc. | 35.91 Million USD | 77.333% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 96.35% |
| Aethlon Medical, Inc. | 2.47 Million USD | -228.353% |
| PAVmed Inc. | 57.13 Million USD | 85.75% |
| BIOLASE, Inc. | 35.34 Million USD | 76.966% |
| Beyond Air, Inc. | 29.77 Million USD | 72.655% |
| FONAR Corporation | 57.45 Million USD | 85.83% |
| AxoGen, Inc. | 101.16 Million USD | 91.952% |
| Vivani Medical, Inc. | 25.03 Million USD | 67.479% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 90.726% |
| Inari Medical, Inc. | 209.32 Million USD | 96.11% |
| UFP Technologies, Inc. | 118.04 Million USD | 93.103% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 35.842% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -272.493% |
| Tenon Medical, Inc. | 5.56 Million USD | -46.255% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -357.673% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 53.828% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.742% |
| Sintx Technologies, Inc. | 6.59 Million USD | -23.495% |
| NanoVibronix, Inc. | 2.68 Million USD | -203.127% |
| Quanterix Corporation | 78.08 Million USD | 89.573% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -127.94% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -66.673% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.221% |
| TransMedics Group, Inc. | 568.84 Million USD | 98.569% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 51.193% |
| NeuroMetrix, Inc. | 1.33 Million USD | -510.746% |
| Hyperfine, Inc. | 9.8 Million USD | 16.918% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 96.746% |
| Biomerica, Inc. | 2.66 Million USD | -205.745% |
| Bone Biologics Corporation | 831.4 Thousand USD | -879.31% |
| AVITA Medical, Inc. | 19.86 Million USD | 59.014% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -312.528% |
| Silk Road Medical, Inc | 114.15 Million USD | 92.868% |